Company Overview of Humacyte, Inc.

Snapshot

People

Overview Board Members Committees

Executive Profile

Carrie Smith Cox

Chairman and Chief Executive Officer, Humacyte, Inc.

Age	Total Calculated Compensation	This person is connected to 5 Board Members in 5 different organizations across 9 different industries. See Board Relationships
55	--

Background

Ms. Carrie Smith Cox has been the Chief Executive Officer of Humacyte Inc., since September 20, 2010. Ms. Cox served as an Executive Vice President and President of Global Pharmaceutical Business at Schering-Plough Corporation from May 15, 2003 to November 3, 2009. She is a 30-year veteran of the pharmaceutical industry. In addition, Ms. Cox was Schering-Plough's executive sponsor for the Merck/Schering-Plough Cholesterol Joint Venture (the "Joint Venture"). She served ... as President of Global Pharmaceuticals and Executive Vice President at Merck & Co. Inc. Ms. Cox joined Schering-Plough in May 2003. Ms. Cox was responsible for leading the transformation of the Global Pharmaceutical Business into a profitable, high-performing organization. Ms. Cox served as an Executive Vice President and President - Global Prescription Business at Pharmacia Corp., from February 2001 to 2003. She has more than 30 years of experience in the pharmaceutical industry. She served as an Executive Vice President and Head of Global Business Management at Pharmacia & Upjohn LLC (formerly, Pharmacia & Upjohn Inc.) from 1997 to March 2000. She joined U.K.-based Pharmacia and Upjohn (Pharmacia's predecessor company) in 1997 as a Senior Vice President. Prior to 1997, she served as Vice President, Women's Health Care of Wyeth-Ayerst Laboratories, a division of Wyeth (formerly American Home Products) until August 1997. Ms. Cox joined Pharmacia's predecessor company, Pharmacia & Upjohn, in 1997 as a Member of Top Management and was a strong contributor to Pharmacia & Upjohn's dramatic turnaround. She serves as Chairman of the Board of Humacyte, Inc. She has been the Chairman of Prism Pharmaceuticals, Inc., since January 11, 2011. She held a variety of positions in market research, sales and product management during a 10-year career with Sandoz Pharmaceuticals. She has been an Independent Director of Texas Instruments Inc. since September 16, 2004 and serves as its Lead Director. She has been a Director of Cardinal Health, Inc. since December 2009 and Celgene Corporation since December 16, 2009. She serves as a Director of Humacyte, Inc. She served as a Director of Lyris, Inc. (formerly, Jl Halsey Corp.) since September 16, 2004. Ms. Cox is a Member of the Harvard School of Public Health's Health Policy and Management Executive Council and is a Member of the Board of Overseers of the University of Pennsylvania Museum of Archaeology and Anthropology. She has been named six times to Fortune magazine's list of the 50 Most Powerful Women in Business. Ms. Cox is a registered Pharmacist and earned a Bachelor's of Science Degree in 1981 from the Massachusetts College of Pharmacy and Health Sciences.

Read Full Background